Rosén, Anders http://orcid.org/0000-0001-6739-6730
Gennser, Mikael
Oscarsson, Nicklas http://orcid.org/0000-0002-0460-1829
Kvarnström, Andreas
Sandström, Göran
Seeman-Lodding, Helen
Simrén, Joel http://orcid.org/0000-0001-5081-6604
Zetterberg, Henrik http://orcid.org/0000-0003-3930-4354
Funding for this research was provided by:
Swedish society for military medical officers
Swedish research council (2018-02532)
European research council (681712)
Swedish state support for clinical research (ALFGBG-720931)
University of Gothenburg
Article History
Received: 22 September 2021
Accepted: 5 January 2022
First Online: 10 February 2022
Declarations
:
: HZ has served at scientific advisory boards for Denali, Roche Diagnostics, Wave, Samumed, Siemens Healthineers, Pinteon Therapeutics and CogRx, has given lectures in symposia sponsored by Fujirebio, Alzecure and Biogen, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program (outside submitted work).
: The datasets generated and analysed during the current study are available from the corresponding author on reasonable request.
: The study was approved by Swedish ethical review authorities as EPN Dnr 352–14 with supplementary approvals T847-15, T1032-18 and 202–05525.
: Written consent to participate was obtained from all study subjects.
: All authors have approved publication of the manuscript.